IBD Flare Prediction
Your Patients Can Share With You
Patients arrive with up to 60 days of objective and subjective data. You start the appointment informed.
The Gap Between Visits
IBD doesn't pause between appointments. But patient recall does.
Patients forget symptoms. Flares are reported after the fact. The first 10 minutes of every visit is spent reconstructing what happened.
Paper diaries are incomplete. Portal questionnaires have low compliance. You're making decisions with incomplete data.
What if patients arrived with up to 60 days of continuous data: objective vitals and validated symptom scores, ready to go?
What You Receive
Patients generate comprehensive PDF reports in 30 seconds. No training required.
Clinical Summary
Risk score (0-7) with wearable vs. symptom breakdown. Device compliance percentage. Remission/flare status at a glance.
Wearable Health Trends
HRV, resting heart rate, sleep duration, steps. Baseline vs. current with trend indicators.
Flare Timeline
When flares occurred, duration, peak severity. Symptoms reported during each episode.
Medication Adherence
Actual adherence percentages by medication. Pattern detection for missed doses.
HBI/SCCAI Scores
Validated clinical indices tracked over time with remission/active thresholds.
Questions for Provider
Auto-generated questions based on patient data patterns.
How It Works
Flarity combines objective wearable data with subjective symptom input. The same methodology you use, now continuous.
Wearable Layer
Apple Watch monitors HRV, heart rate, sleep, temperature, activity, and SpO2. Deviations from personal baseline trigger symptom prompts.
Symptom Layer
Brief check-ins based on HBI (Crohn's) or SCCAI (UC). 30 seconds, only when needed. No survey fatigue.
Combined Score
Wearables alone can't assess pain. Symptoms alone rely on memory. Combined assessment gives the complete picture.
No Portal. No Logins. No Burden.
Flarity requires nothing from your practice.
Patients share reports via email, AirDrop, or upload to your existing portal
Clinically formatted data using HBI, SCCAI, and Montreal Classification
Works alongside your current EHR workflow
EHR integration (FHIR, Epic MyChart) on our roadmap. Contact us for early access.
Built on Peer-Reviewed Science
"Wearable devices can detect and predict IBD flares through changes in heart rate variability and resting heart rate, often days before symptoms appear."
Flarity was created by a founder living with Crohn's disease. Someone who's been through the ER visits, the scope preps, the uncertainty between appointments.
After an ileocecal resection in 2024, he built the tool he wished existed: continuous monitoring that speaks his gastroenterologist's language. With 15 years of B2B SaaS leadership and deep experience in GRC and compliance, the founder brings both the patient perspective and the enterprise expertise needed to build a clinically-credible, privacy-first solution.
Flaresense Inc. | Toronto, Canada
Easy for Patients. Valuable for You.
iOS app (iPhone required). Works with or without a wearable.
All wearables sync via Apple Health. Apple Watch provides the richest data with real-time monitoring.
What Patients See Before Their Visit
Patients arrive prepared with AI-generated reports and smart talking points—reducing time spent on history taking
One-Tap Report Generation
Patients generate comprehensive PDF reports in 30 seconds—vitals, symptoms, flare history, and trends formatted for clinical review
AI-Suggested Discussion Points
Patients receive personalized questions based on recent symptoms, flares, and medication changes—so visits focus on what matters
Common Questions
Patients generate PDF reports in the app with one tap. They can share via email, AirDrop, or upload to your patient portal. No integration required on your end.
Flarity is an iOS app (iPhone required). For wearables, it works with Apple Watch (best experience), Oura Ring, Whoop, Garmin, and Fitbit, all via Apple Health sync. Patients without a wearable can still use iPhone-only mode with symptom tracking and basic activity data.
Harvey-Bradshaw Index (HBI) for Crohn's disease, Simple Clinical Colitis Activity Index (SCCAI) for ulcerative colitis, and Montreal Classification for disease location/behavior. The same validated tools you use.
Flarity is a wellness application, not an FDA-cleared medical device. It's designed to support patient self-tracking and clinician communication, not to diagnose or treat.
Not yet, but EHR integration (FHIR, Epic MyChart) is on our roadmap. Currently, patients share reports directly with you. Interested in early integration access? Contact us.
Patients can try Flarity free for 21 days. After that, plans are $14.99/month or $149/year. There's no cost to you or your practice.
The 2025 Mount Sinai study detected flare signals up to 7 weeks early under research conditions. Flarity conservatively targets up to 4 weeks advance warning to account for real-world variability and ensure clinically actionable accuracy. Prediction improves as the app learns each patient's personal baseline over time.
Get in Touch
Questions about Flarity? Interested in a pilot program or EHR integration?
Or email us directly:
support@getflarity.ai